Panels
of experts write the asthma guidelines based on their experience and available
scientific information. (The guidelines
are not divinely inspired or carved in stone tablets!) Asked to define “persistent asthma,” the
experts reached the following consensus: anyone who has two days or more of
asthma symptoms each week or wakes
up two or more times with asthma symptoms each month or has lung function that is below normal or has had two or more attacks of asthma (requiring oral steroids)
in the past year. Taken as a whole,
patients with persistent asthma who are treated with regular (daily) inhaled
steroids have fewer symptoms of their asthma, less need for their “rescue”
bronchodilator, better lung function, fewer asthma attacks, and an overall
improved sense of well-being.
But
a fair question – and one that has now been addressed by recent clinical
research – is exactly where one should draw the line between “intermittent” and
“persistent” asthma. Did the experts get
it right, or are there patients with persistent (as defined above) but mild asthma
who do not in fact need to take an anti-inflammatory medication daily for
relief of symptoms and prevention of asthmatic attacks? If you have mild persistent asthma and your
symptoms are sufficiently few (more than two days out of the week but less than
every day), prior asthma attacks have been sufficiently rare, and breathing
tests are for the most part normal, might you take inhaled steroids only during
periods when your asthma is troublesome but stop them during times when your
asthma is no longer bothering you? It is
very likely that many patients with asthma have been following this practice
for years – because daily medication use can be onerous – but is it safe and
advisable?
Two
studies – one in adults [Boushey et al., New England Journal of Medicine 2005; 352:1519] and one in
young children [Zeiger et al., New England
Journal of Medicine 2011; 365:1990] – have indicated that the strategy of using inhaled
steroids intermittently, only during periods of increased symptoms, is indeed
safe for persons with mild persistent
asthma. These studies found that among
persons with mild persistent asthma there was no difference in the frequency of
asthma attacks, including severe or dangerous attacks, and very little overall
difference in sense of well-being whether they used their inhaled steroids
every day vs. used them only when symptoms became troublesome … as long as
everyone had a plan regarding how to deal with an asthma attack.
Let’s
be specific. Based on these recent
studies, if your asthma has been mild, your medical provider might prescribe
for you an albuterol (ProAir, Proventil, or Ventolin) or levalbuterol (Xopenex)
inhaler to use whenever you need it. If
you find yourself using your quick-relief bronchodilator a lot, or if you feel
congested at the start of a “cold,” or if you are visiting your in-laws who own
a cat to which you are allergic, you would begin your steroid inhaler, such as
fluticasone (Flovent), budesonide (Pulmicort), beclomethasone (Qvar),
mometasone (Asmanex), or ciclesonide (Alvesco).
You would probably take at least four
inhalations morning and night every day for approximately ten days, and then
when you felt better, didn’t need your rescue bronchodilator so often, had
gotten over the cold, or were no longer exposed to the pet cat, stop your
steroid inhaler. And you would be
prepared with the knowledge that if your symptoms worsened despite taking the
inhaled steroid, you would need to begin oral steroids (e.g., prednisone or
Medrol) and be in contact with your healthcare provider.
Two
important caveats before one puts this approach into practice. First, it is not intended for persons with
more severe forms of asthma. Our
emergency departments routinely treat persons with asthma who had been doing
well until they stopped taking their preventive asthma medication (their
inhaled steroids), thinking that they no longer needed them, and then developed
severe asthma symptoms. In persons with
moderate and severe persistent asthma, evidence is unequivocal that reducing
the dose and then stopping inhaled steroids is associated with more asthma
attacks and worse asthma control.
Second, intermittent use of inhaled steroids does not mean “as needed”
or “p.r.n.” For this new strategy to
work, the inhaled steroids need to be taken not here and there trying to
relieve symptoms but every day, usually twice a day, for a period of 1-2 weeks
or more. Intermittent use of inhaled
steroids refers to regular, daily administration, but for a limited period of
time rather than year-round indefinitely.
In the future, another group of national and international asthma experts will write an updated set of asthma guidelines and render its opinion regarding this approach to asthma care. In the meantime, our opinion is that this is a safe and reasonable way to treat mild asthma. It is not appropriate for persons whose asthma is more severe, and its implementation requires careful explanation and reinforcement such that everyone is clear as to when to begin the inhaled steroids, how to use them and for how long, and what to do if asthma fails to improve as expected.